General MedicationsINJECTIONStandard
NUTROPIN AQ NUSPIN
SOMATROPIN
Standard Dose
10MG/2ML (5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NUTROPIN AQ NUSPIN is listed in Drugs@FDA under application 020522 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SOMATROPIN Form and strength INJECTABLE;INJECTION - 10MG/2ML (5MG/ML) Sponsor GENENTECH Submission history Latest submission status date: 2025-07-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview NUTROPIN AQ NUSPIN is listed in Drugs@FDA under application 020522 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient SOMATROPIN Form and strength INJECTABLE;INJECTION - 10MG/2ML (5MG/ML) Sponsor GENENTECH Submission history Latest submission status date: 2025-07-09 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.